Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Outfront Media Executive Vice President and Chief Financial Officer Matthew Siegel disposed of 50,000 shares on March 31, 2026, generating $1.29 million in proceeds. The sale, executed under a Rule 10b5-1 plan adopted in December 2025, occurred while the stock traded close to its 52-week peak. The company recently reported fourth-quarter 2025 resul…
Snowflake Inc. SVP of Engineering Vivek Raghunathan executed a sale of 3,876 shares on April 1, 2026, generating $592,252 in proceeds under a pre-arranged 10b5-1 plan. The transaction was disclosed in a Form 4 filing. The company also named Jonathan Beaulier as Chief Revenue Officer following Mike Gannon's departure, a move noted by several analyst…
DocuSign Chief Revenue Officer Paula Hansen sold 6,000 shares of DOCU on April 1, 2026 under a prearranged 10b5-1 plan, generating $281026. The trades were split across three executions at price ranges between $45.85 and $48.00. Following the sales Hansen retains direct ownership of 79,233 shares. The move comes as the stock trades near its 52-week…
DocuSign President and CEO Allan C. Thygesen sold 26,250 shares of the company's common stock on April 1, 2026, generating roughly $1.25 million in proceeds. The transactions were executed in three tranches at prices between $45.89 and $48.38 and were carried out under a Rule 10b5-1 plan. Following the sales Thygesen retains direct ownership of 152…
DocuSign Chief Legal Officer James P. Shaughnessy executed the sale of 12,000 shares on April 1, 2026, under a pre-established Rule 10b5-1 plan, generating proceeds of $562,011. The trades were split across three price bands. The sale occurs amid mixed analyst signals, price-target cuts and growing focus on AI revenue as a potential catalyst for th…
WEX Inc. COO Joel Alan Dearborn Jr. sold 3,503 shares on April 1, 2026, through an automatic Rule 10b5-1 plan for $532,488. The shares traded between $147.93 and $152.71. WEX reported stronger-than-expected fourth-quarter 2025 results and continues active buybacks, yet shares declined amid broader market concerns and analysts maintained neutral-to-…
Netflix director Reed Hastings sold $40.1 million in company shares on April 1, 2026, while exercising options and acquiring additional option rights. The moves come as Netflix implements U.S. subscription price increases and pursues an expanded NFL game package, with several analysts maintaining positive ratings and price targets.
Travere Therapeutics CEO Eric M. Dube sold 60,000 shares of company stock on April 1, 2026, in two tranches for roughly $1.8 million while exercising options to acquire 60,000 shares the same day. The transactions were conducted under a June 16, 2025 written 10b5-1 plan and follow a year in which the stock has risen 70%. Separately, the FDA pushed …
Elizabeth E. Reed, Travere Therapeutics' chief legal officer and general counsel, sold 10,000 shares of the company's common stock on April 1, 2026, for $300,000 and exercised options for an additional 10,000 shares the same day. The company is concurrently managing an extended FDA review for its Filspari supplemental New Drug Application, with a n…
SoftVest, L.P. purchased 12,893 units of Cross Timbers Royalty Trust (CRT) on March 31 and April 1, 2026, paying roughly $10.50 per unit for a total outlay of $135,376, according to a Securities and Exchange Commission Form 4 filing. The purchases raised SoftVest's direct ownership to 710,744 units as CRT shares trade near $10.75 and InvestingPro f…
Andrew Shafer, Gevo's Chief Customer, Market & Brand Officer, sold 5,550 shares on April 1, 2026, receiving $15,027 and on the same day exercised options to acquire 5,550 shares at $0.71. The transactions were carried out under a 10b5-1 trading plan adopted November 19, 2025. Following the activity Shafer holds 270,823 shares directly and 16,871.52…
Qualcomm SVP and Chief Accounting Officer Patricia Y. Grech sold 85 shares on April 2, 2026, under a pre-arranged Rule 10b5-1 plan. The trade, worth $10,667 at $125.50 per share, comes as Qualcomm shares trade near a 52-week low and following company moves to raise its dividend and authorize a large buyback program. Analysts have issued mixed ratin…
Gregory D. Patrinely, Sable Offshore Corp's executive vice president and chief financial officer, disposed of 279,081 shares on March 31, 2026, in a Form 4 filing. The sale, executed at $16.6893 per share for a total of $4,657,666, was reported as a tax-withholding action tied to restricted stock vesting. Sable Offshore is concurrently reporting op…
Steel Connect Sub LLC increased its direct holding in Spruce Power Holding Corp through two purchases totaling 12,637 shares for $50,913. The transactions were disclosed in a Form 4 filing that lists a group of reporting entities potentially part of a 13(d) group holding more than 10% of Spruce Power's common stock. Separately, Spruce Power reporte…
Dmitry Zamansky, Amwell's Chief Product & Technology Officer, sold 5,575 Class A shares on April 1, 2026, in an automatic sell-to-cover tied to restricted stock unit vesting. The transaction raised $29,547 at $5.30 per share. The firm reported a 22.1% year-over-year revenue decline in Q4 2025, a loss of $5.96 per share over the trailing twelve mont…
Nasdaq Inc. Chair and CEO Adena T. Friedman executed employee stock options for 113,611 shares and concurrently sold the same number of shares on April 1, 2026. The stock sale generated $9.71 million at an average price of $85.44. Nasdaq also updated medium-term revenue guidance and disclosed partnerships and tokenization plans.
Entrada Therapeutics Chief Financial Officer Wentworth Kory James sold 2,500 shares of common stock on April 1, 2026 for $12.95 per share, a transaction totaling $32,375. The sale, carried out under a Rule 10b5-1 plan adopted in March 2025, leaves Wentworth with direct ownership of 119010 shares. The divestiture comes as TRDA trades near its 52-wee…
Lightwave Logic director Ronald A. Bucchi sold 11,000 shares of common stock on April 1, 2026, at a weighted average price of $6.92, generating about $76,120. The disposition followed the conversion of restricted stock units that vested on March 31, 2026, and was executed to meet tax withholding obligations. The company reported a 147% year-over-ye…
Martine Rothblatt, Chairperson and CEO of United Therapeutics (UTHR), carried out multiple transactions on April 1, 2026, selling $5.5 million of company common stock at prices between $570.8668 and $596.1083 and exercising options for 9,500 shares at $146.03. The trades were made under a 10b5-1 trading plan adopted on November 7, 2025. Analysts su…
Presurance Holdings Chief Executive Officer Brian J. Roney purchased 100,000 shares of company common stock on April 1, 2026, at a weighted average price of $0.7181, costing $71,810. The company recently completed a rights offering that generated $14 million in gross proceeds and received a Nasdaq notice regarding non-compliance with the minimum bi…
David V. Elkins, Executive Vice President and Chief Financial Officer of Bristol Myers Squibb (BMY), sold 30,000 shares of company stock on April 1, 2026, in two transactions totaling roughly $1.85 million. The trades were carried out under a pre-arranged Rule 10b5-1 plan put in place on June 3, 2025. The stock has risen sharply over six months and…
Daniel J. Sajkowski, a director at Calumet, Inc. /DE (NASDAQ: CLMT), sold 3,310 shares of common stock on April 1, 2026 under a Rule 10b5-1 trading plan, generating $114,062 at a weighted average price of $34.46. The transaction occurred while CLMT traded near its 52-week high. Separately, Calumet disclosed an unplanned maintenance outage at its Sh…
Edward Meyercord, president and CEO of Extreme Networks, sold 50,000 shares on April 1, 2026, for $765,185 and simultaneously exercised options to acquire 50,000 shares at $6.70. The company reported a second-quarter 2026 earnings beat and was flagged by Wolfe Research for high activist attractiveness; the stock has fallen 26% over the past six mon…
Twilio Inc. Chief Financial Officer Aidan Viggiano completed $1,010,653 in Class A share sales on March 31, 2026, via a series of sell-to-cover transactions mandated under the company’s equity incentive plan. The trades, disclosed on a Form 4 filing, reduced withholding obligations but do not reflect discretionary selling. Twilio’s stock trades abo…
Charles van Es, Chief Commercial Officer at The Vita Coco Company, Inc. (NASDAQ: COCO), sold 2,000 shares on April 1, 2026, for $97,340 under a Rule 10b5-1 plan. The transaction follows a 61% 12-month stock run and comes amid analyst price-target increases and a board appointment for retail executive Shelley Broader. Analysis tools cited in filings…
